Literature DB >> 22265067

Cost-effectiveness of various tuberculosis control strategies in Thailand.

Pojjana Hunchangsith1, Jan J Barendregt, Theo Vos, Melanie Bertram.   

Abstract

OBJECTIVE: To evaluate the cost-effectiveness of different tuberculosis control strategies in Thailand.
METHODS: Different tuberculosis control strategies, which included health-worker, community-member, and family-member directly observed treatment (DOT) and a mobile phone "contact-reminder" system, were compared with self-administered treatment (SAT). Cost-effectiveness analysis was undertaken by using a decision tree model. Costs (2005 international dollars [I$]) were calculated on the basis of treatment periods and treatment outcomes. Health outcomes were estimated over the lifetime of smear-positive pulmonary tuberculosis patients in disability-adjusted life years (DALYs) averted on the basis of Thai evidence on the efficacy of the selected strategies.
RESULTS: Cost-effectiveness results indicate no preference for any strategy. The uncertainty ranges surrounding the health benefits were wide, including a sizeable probability that SAT could lead to more health gain than DOT strategies. The health gain for family-member DOT was 9400 DALYs (95% uncertainty interval -7200 to 25,000), for community-member DOT was 13,000 DALYs (95% uncertainty interval -21,000 to 37,000), and for health-worker DOT was 7900 DALYs (95% uncertainty interval -50,000 to 43,000). There were cost savings (from less multi-drug resistant tuberculosis treatment) associated with family-member DOT (-I$9 million [95% uncertainty interval -I$12 million to -I$5 million]) because the trial treatment failure rate was significantly lower than that for SAT. The mobile phone reminder system was not cost-effective, because the mortality rate associated with it was much higher than that associated with other treatment strategies.
CONCLUSIONS: Because of the large uncertainty intervals around health gain for DOT strategies, it remains inconclusive whether DOT strategies are more cost-effective than SAT. It is evident, however, that family-member DOT is a cost-saving intervention.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265067     DOI: 10.1016/j.jval.2011.11.006

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  11 in total

1.  Engaging Patients through Mobile Phones: Demonstrator Services, Success Factors, and Future Opportunities in Low and Middle-income Countries.

Authors:  A Hartzler; T Wetter
Journal:  Yearb Med Inform       Date:  2014-08-15

2.  What is the clinical effectiveness and cost-effectiveness of using digital health technologies to improve treatment -adherence and outcomes in patients with tuberculosis?

Authors:  Kartik Kumar; Saira Ghafur
Journal:  Future Healthc J       Date:  2019-06

Review 3.  Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment.

Authors:  Qin Liu; Katharine Abba; Marissa M Alejandria; David Sinclair; Vincent M Balanag; Mary Ann D Lansang
Journal:  Cochrane Database Syst Rev       Date:  2014-11-18

Review 4.  Assessing the impact of mHealth interventions in low- and middle-income countries--what has been shown to work?

Authors:  Charles S Hall; Edward Fottrell; Sophia Wilkinson; Peter Byass
Journal:  Glob Health Action       Date:  2014-10-27       Impact factor: 2.640

Review 5.  What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions.

Authors:  Sarah J Iribarren; Kenrick Cato; Louise Falzon; Patricia W Stone
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

6.  Forecasting the Value for Money of Mobile Maternal Health Information Messages on Improving Utilization of Maternal and Child Health Services in Gauteng, South Africa: Cost-Effectiveness Analysis.

Authors:  Amnesty LeFevre; Jesse Coleman; Maria A Cabrera-Escobar; Diwakar Mohan; Jaran Eriksen; Debbie Rogers; Annie Neo Parsons; Iman Barre; Youngji Jo; Alain Labrique
Journal:  JMIR Mhealth Uhealth       Date:  2018-07-27       Impact factor: 4.773

7.  Toward Developing a Standardized Core Set of Outcome Measures in Mobile Health Interventions for Tuberculosis Management: Systematic Review.

Authors:  Seohyun Lee; Youngji Lee; Sangmi Lee; Sheikh Mohammed Shariful Islam; Sun-Young Kim
Journal:  JMIR Mhealth Uhealth       Date:  2019-02-19       Impact factor: 4.773

8.  Mobile Technology for Community Health in Ghana: Is Maternal Messaging and Provider Use of Technology Cost-Effective in Improving Maternal and Child Health Outcomes at Scale?

Authors:  Michelle Willcox; Anitha Moorthy; Diwakar Mohan; Karen Romano; David Hutchful; Garrett Mehl; Alain Labrique; Amnesty LeFevre
Journal:  J Med Internet Res       Date:  2019-02-13       Impact factor: 5.428

9.  Costs and cost-effectiveness analyses of mCARE strategies for promoting care seeking of maternal and newborn health services in rural Bangladesh.

Authors:  Youngji Jo; Amnesty E LeFevre; Katherine Healy; Neelu Singh; Kelsey Alland; Sucheta Mehra; Hasmot Ali; Saijuddin Shaikh; Rezawanul Haque; Parul Christian; Alain B Labrique
Journal:  PLoS One       Date:  2019-10-01       Impact factor: 3.240

10.  Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.

Authors:  Paresh Vamanrao Dave; Amar Niranjan Shah; Pankaj B Nimavat; Bhavesh B Modi; Kirit R Pujara; Pradip Patel; Keshabhai Mehariya; Kiran Vaman Rade; Soma Shekar; Kuldeep S Sachdeva; John E Oeltmann; Ajay M V Kumar
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.